Daenen W, Narine K, Goffin Y, Gewillig M
Department of Cardiac Surgery, University Hospital Gasthuisberg, Leuven, Belgium.
Eur J Cardiothorac Surg. 1995;9(8):448-51; discussion 451-2. doi: 10.1016/s1010-7940(05)80081-8.
Ninety children and young adults underwent right ventricular outflow tract (RVOT) reconstruction with aortic or pulmonary homografts from May, 1989 to May, 1994. The patients were divided into three groups according to preoperative diagnosis: RVOT obstructions with ventriculo-arterial (VA) concordance (61), RVOT obstructions with VA discordance (18) and truncus arteriosus (11). Of the reconstructions, 52% were reoperations. A pulmonary homograft was used by preference (85% in the concordant group and 33% in the discordant group). One patient died after homograft correction (hospital mortality 1.1%). The mean follow-up was 32 +/- 22 months. One patient died after 10 months due to congestive heart failure and obstructive pulmonary hypertension. All other patients were in NYHA classes I-II. Three patients (two discordant and one truncus correction) underwent reoperation because of aortic homograft dysfunction and calcification. The incidence of significant (> or = 40 mmHg) gradient across the reconstruction found at the last echocardiographic control was 4% in the concordant, 28% in the discordant, and 18% in the truncus, group. Echocardiographic evidence of moderate (grade 2-3/4) pulmonary regurgitation (PR) was noticed in 24 and 13% of the concordant and discordant groups, respectively. From this medium-term experience it is concluded that (1) the medium-term performance of cryopreserved homografts is excellent, even in young patients, (2) corrections in patients with VA discordance need close follow-up, (3) the use of pulmonary homografts, especially in VA concordant lesions, should be encouraged, (4) longer-term follow-up is necessary to confirm the superiority of the cryopreserved homograft when compared to the porcine xenograft in the RVOT.
1989年5月至1994年5月期间,90名儿童和年轻成人接受了使用主动脉或肺动脉同种异体移植物的右心室流出道(RVOT)重建手术。根据术前诊断,患者被分为三组:心室动脉(VA)一致的RVOT梗阻(61例)、VA不一致的RVOT梗阻(18例)和动脉干(11例)。在这些重建手术中,52%是再次手术。优先使用肺动脉同种异体移植物(一致组为85%,不一致组为33%)。1例患者在同种异体移植矫正后死亡(医院死亡率1.1%)。平均随访时间为32±22个月。1例患者在10个月后因充血性心力衰竭和阻塞性肺动脉高压死亡。所有其他患者的心功能分级为纽约心脏协会(NYHA)I-II级。3例患者(2例不一致组和1例动脉干矫正组)因主动脉同种异体移植物功能障碍和钙化接受了再次手术。在上次超声心动图检查时,重建部位显著(≥40 mmHg)压差的发生率在一致组为4%,不一致组为28%,动脉干组为18%。分别在一致组和不一致组的24%和13%的患者中发现了中度(2-3/4级)肺动脉反流(PR)的超声心动图证据。从这一中期经验得出以下结论:(1)即使在年轻患者中,冷冻保存的同种异体移植物的中期性能也非常出色;(2)VA不一致患者的矫正需要密切随访;(3)应鼓励使用肺动脉同种异体移植物,尤其是在VA一致的病变中;(4)需要更长时间的随访以证实与猪异种移植物相比,冷冻保存的同种异体移植物在RVOT中的优越性。